Pathogenic microorganisms are inactivated by physical or chemical methods to make inactivated vaccines. Inactivated vaccines lose their pathogenicity but retain good immunogenicity. Inactivated vaccines have been used to prevent viral or bacterial infections, such as the human typhoid Salmonella inactivated vaccine, as well as animal vaccines such as the swine erysipelas inactivated vaccine, piglet Escherichia coli inactivated vaccine, Haemophilus parasuis inactivated vaccine, multi-kill Bacillus inactivated vaccine, and swine bronchial septicemia Bordetella inactivated vaccine.
Yaohai Bio-Pharma has more than ten years of microbial CDMO experience. Based on the Biosafety Level 1 (BSL-1) and Biosafety Level 2 (BSL-2) operation area, we provide a one-stop solution from microbial strain development to GMP production of inactivated vaccines.
Based on the customized needs of customers, we provide customers with inactivated vaccine bulk (DS, API) or formulation (DP) that meet quality standards, as well as GMP production records and test reports.
Inactivated Vaccine Drug Product Process
Deliverables
|
Grade
|
Deliverables
|
Specification
|
Applications
|
|
GMP, BSL-1/BSL-2
|
Drug Substance
|
Inactive bacteria
|
Investigational new drug (IND),
Clinical trial authorisation (CTA),
Clinical trial supply,
Biologic license application (BLA),
Commercial supply
|
|
Drug Product
|
Vials (liquid)
|
|
Vials (lyophilized)
|
|
Other dosage forms
|
EN
AR
HR
CS
DA
NL
FI
FR
DE
EL
IT
JA
KO
NO
PL
PT
RO
RU
ES
SV
IW
ID
LV
LT
SR
SK
SL
UK
VI
ET
HU
TH
TR
FA
AF
MS
BE
MK
UR
BN
